The collaboration will place T1D in the field of precision medicine, potentially allowing JDRF to identify factors that potentially lead to T1D.
Investigators will use Biocept's liquid biopsy tests to detect ALK rearrangements both at baseline and to monitor treatment response and resistance mechanisms.
The study, launched today, aims to evaluate the use of liquid biopsy and natural killer cell testing for the early detection of recurrent breast cancer.
The companies will integrate Cambridge's TrueMethyl technology for oxidative bisulfite sequencing with NuGen's sequencing library preparation kits.
NanoString also beat analyst estimates on the top and bottom lines, and upped its revenue guidance for the year based primarily on collaboration revenues.
The partners aim to enable the early prediction of clinical efficacy of Alligator's pipeline candidates by analyzing potential systemic biomarkers.
Under the agreement MedStar will contribute to Indivumed’s biobank of annotated tumor and liquid biospecimen samples, and gain research access to this larger database.
Coimbra Genomics' platform, Elsie, will be used for analysis of clinical cases at the medical genetics unit of Coimbra Hospital and Universitary Centre.
The newly announced tie-up wants to alleviate the shortage of bioinformaticists by taking over data management and storage for genomics researchers.
The new partnership between Cloudian, OnRamp Bioinformatics, and ScaleMatrix seeks to cut the costs and processing time of sequencing analysis.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.